Ajanta Pharma Q4 Results
- BSE: 532331
- NSE: AJANTPHARM
- ISIN: INE031B01049
- Sector: Biotechnology & Drugs
BSE
3,098.00
33.05 (1.08%)
33.05 (1.08%)Volume28.43 K
Updated: Tue 12 May, 2026 | 15:29:53
NSE
3,091.7027.50 (0.90%)
27.50 (0.90%)Volume2.38 L
Updated: Tue 12 May, 2026 | 15:41:30
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹1,421.64 Cr.(21.47%)
- Operating Profit₹288.04 Cr.(11.92%)
- Profit After Tax₹266.70 Cr.(18.40%)
- Operating Margin20.26%(-7.86%)
Note: Comparison is on YoY basis
Quarterly - Ajanta Pharma Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1,133.60 | 1,036.11 | 9.41% | 810.01 | 24.16% |
| Depreciation/ Amortization | 45.37 | 43.51 | 4.27% | 34.25 | 14.05% |
| Operating Income | 288.04 | 338.73 | -14.96% | 244.07 | 11.92% |
| Net Income | 266.70 | 273.77 | -2.58% | 202.72 | 18.40% |
| Net Income Before Taxes | 347.11 | 358.60 | -3.20% | 278.04 | 28.84% |
| Other Operating Expenses Total | 442.70 | 375.82 | 17.80% | 277.87 | 42.78% |
| Total Revenue | 1,421.64 | 1,374.84 | 3.40% | 1,054.08 | 21.47% |
| Selling/ General/ Admin Expenses Total | 340.72 | 330.52 | 3.09% | 233.51 | 21.78% |
| Diluted Normalized EPS | 21.34 | 21.91 | -2.60% | 16.09 | 18.32% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.